How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs
John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products.
Related Resources
Advisories
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Advisories
The Food and Drug Administration (FDA) UDI system is being phased in over several years.
Guides and Reports
In the fall of 2014, the University of Houston conducted a national study on hospital supply chain.
Guides and Reports
In 2001 the Institute of Medicine (IOM) published
Advisories
An overview of Fiscal Year (FY) 2015 Hospital Value-Based Purchasing (VBP) Program.
Pagination
- First page
- Previous page
- More previous pages available
- Page 18
- Page 19
- Page 20
- Page 21
- Page 22
- Page 23
- Page 24
- Current page 25
- Page 26
- Next page
- Last page